Search company, investor...

IntElect Medical

Founded Year



Acquired | Acquired

Total Raised




About IntElect Medical

Intelect Medical designs, develops and manufactures Deep Brain Stimulation (DBS) systems based on intellectual property developed at the Cleveland Clinic's Center for Neurological Rehabilitation. Research, pre-clinical and clinical studies, and customer requirements research is conducted to verify the safety and efficacy of the DBS system and its therapy.In January 2011, IntElect Medical was acquired by Boston Scientific Corporation. The valuation of IntElect Medical was $60 million. Other terms of the deal were not released.

Headquarters Location

1300 East 9th Street Suite 605

Cleveland, Ohio, 44114,

United States

Missing: IntElect Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: IntElect Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

IntElect Medical Patents

IntElect Medical has filed 1 patent.

The 3 most popular patent topics include:

  • Electrotherapy
  • Implants (medicine)
  • Neurophysiology
patents chart

Application Date

Grant Date


Related Topics




Neurotechnology, Electrotherapy, Neurophysiology, Implants (medicine), Neuroprosthetics


Application Date


Grant Date



Related Topics

Neurotechnology, Electrotherapy, Neurophysiology, Implants (medicine), Neuroprosthetics



Latest IntElect Medical News

Share or Leave a Comment Boston Scientific Invests in Intelect

Aug 14, 2013

Submit to Hacker News Boston Scientific (NYSE: BSX ), a Natick, MA-based medical devices firm, has led an equity round expected to total $11 milion to $13.5 million in Intelect Medical, a developer of an implantable neuromodulation system headquartered in Cleveland, Intelect reports in a statement . Intelect says, as part of the deal, it has granted Boston Scientific co-exclusive rights to its software under development to provide graphical information on electrical changes made by electrodes in the brain.

IntElect Medical Frequently Asked Questions (FAQ)

  • When was IntElect Medical founded?

    IntElect Medical was founded in 2005.

  • Where is IntElect Medical's headquarters?

    IntElect Medical's headquarters is located at 1300 East 9th Street, Cleveland.

  • What is IntElect Medical's latest funding round?

    IntElect Medical's latest funding round is Acquired.

  • How much did IntElect Medical raise?

    IntElect Medical raised a total of $14M.

  • Who are the investors of IntElect Medical?

    Investors of IntElect Medical include Boston Scientific, Integer, BIOMEC, Cleveland Clinic and Cornell University.

  • Who are IntElect Medical's competitors?

    Competitors of IntElect Medical include AlterG, iMMCO Diagnostics, BrainScope, ContraVac, Ulthera and 11 more.

Compare IntElect Medical to Competitors

iMMCO Diagnostics

IMMCO Diagnostics provides high-quality diagnostic test kits and lab testing services worldwide for the screening of autoimmune disorders. IMMCO Diagnostics incorporates working on research, clinical laboratory expertise, and medical devices into an approach to autoimmune diagnostics.


PsychNostics, LLC has developed a diagnostic blood test for Bipolar Disorder and ADHD. This propreitory test uses the Membrane Potential Ratio ( MPR ) as a diagnostic blood test marker for Bipolar Disorder (BPD) and Attention Deficit Hyper Active Disorder (ADHD). The test results have been published in peer reviewed scientific journals. Clinical psychiatrists have validated the reliability of this test through clinical trials. PsychNostics, LLC is currently engaged in the development of broader uses of this technology nationwide. Further research is underway to elucidate the biological pathway and the proteins involved so that they could be used as drug targets for developing more effective drugs for these illnesses. Efforts are being made to partner co-development and marketing arrangements with other companies to develop these technologies.

Pulse Metric

Pulse Metric designs, manufactures and markets products and services that transform a simple blood pressure reading into a powerful functional profile of the patients cardiovascular system, including cardiac output, vessel compliance, vascular resistance and left ventricular contractility. Within a minute of uploading a DynaPulse blood pressure waveform to the DynaPulse Analysis Center website, 17 hemodynamic parameters are calculated, displayed and trended, providing clinicians with numeric values profiling the hearts pumping performance, blood vessel elasticity and vascular resistance, against normative ranges.The company believes the simplicity of its methodology and the significance of the information provided to the physician will improve quality of care while reducing costs. Pulse Metric has been granted nine patents in support of its proprietary technology.


Lumiphore is a research company developing lanthanide technology for use in high-value applications and commercializing the technology by entering into market-specific alliances with corporate partners. Lumiphore develops and markets biological detection systems based on luminescent lanthanide complexes, which provide a combination of sensitivity, reliability, flexibility and high throughput.

LifeLineLab S.r.l.

Lifelinelab s.r.l. started its activities in April 2003, thanks to the commitment of three managers coming from the ex Diagnostic Division Manufacturing Plant of Alfa Wassermann S.P.A. First step has been to secure raw materials, and equipment for R&D and Manufacturing of products and services in the field of Human in Vitro Diagnostics. nnnnnFirst diagnostic reagents were manufactured, in this site, over 40 years ago, through the bravery and the enterprising spirit of Prof. Balducci ex Managing Director of Virology Laboratory of "Istituto Superiore di Sanitu00e0". First products were based on tissue colture technology included a line of complement fixation antigens. Since then, the company developed methods and products, covering almost all the fields of Human in Vitro Diagnostics, from Clinical Chemistry to Immunochemistry. The mostly developed sector has been that of Infectious Diseases with particular regard to Viral pathologies. Most products have been developed using biological raw materials derived from in house, in vivo or in vitro, productions. Nowadays the company aims to face and develop markets with consolidate and emerging technologies such as Microarrays using a chemistry patented and designed to covalently bind either Protein or Nucleic acids which aims to allow the development of extremely sophisticated analysis in the emerging applications of proteomics and genomics.

Minomic International

Minomic International specializes in the development and commercialization of diagnostic products.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.